CVRx is a medical device company that develops implantable technology for the treatment of high blood pressure. Its products include Rheos implantable pulse generator that provides control and delivery of the activation energy; and Rheos carotid sinus leads, which conducts activation energy from the Rheos implantable pulse generator to the left and right carotid arteries. The company also offers a Rheos programmer system that communicates with the Rheos pulse generator. CVRx was founded in 2001 and is based in Minneapolis, Minnesota.

Cardiac Pacemakers, Inc.(CPI), doing business as Guidant Cardiac Rhythm Management, manufactured implantable cardiac rhythm management devices, such as pacemakers and defibrillators. It also sold insulin pumps controlled by microprocessors and various equipments to regulate heart rhythm. In addition, Cardiac Pacemakers, Inc. developed therapies for the treatment of irregular heartbeats. The company was founded in 1971 and is based in St. Paul, Minnesota. Cardiac Pacemakers, Inc. operates as a subsidiary of Boston Scientific Corporation.

Sympara Medical, Inc. develops novel therapy for hypertension. It offers devices to treat hypertension. The company was founded by Uday N. Kumar in 2012 and is headquartered in San Francisco, CA.

Vascular Dynamics, Inc. (VDI) is a privately-held company founded in 2008 by Rainbow Medical Ltd. (Rainbow). Rainbow is a healthcare accelerator developing the technologies invented by Israeli inventor, Yossi Gross. In November 2011, VDI's development and commercialization efforts were moved to Mountain View, CA. VDI has developed a passive, catheter-delivered implant for the treatment of high blood pressure, also referred to as hypertension. Collectively, the VDI team has over 75 years of experience developing and commercializing medical devices.

ReShape Lifesciences is America's premier weight-loss solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band® System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational (outside the U.S.) minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. It helps enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy. T

Gross & Co. provided legal services. The company was headquartered in Suffolk, the United Kingdom.

Pacesetter, Inc., a subsidiary of Abbott Laboratories, is a company headquartered in the United States that manufactures, and distributes cardiovascular and implantable neuro stimulation medical devices.

EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN.

Cyberonics is committed to advancing device-based solutions that improve the lives of patients and their families. Their core beliefs guide us to design, develop and market patient-focused medical device solutions for people affected by epilepsy, depression, and other chronic disorders.

Shockwave Medical is developing the Lithoplasty™ family of balloon dilatation catheters that incorporate tiny lithotripsy electrodes designed to increase the compliance of rigid vascular and valvular lesions prior to low-pressure dilation, thereby limiting injury to healthy tissue and overcoming significant limitations of current revascularization technologies. The technology is built on traditional balloon catheter platforms rendering it inherently familiar and easy to use for cardiologists, interventional radiologists and vascular surgeons alike. In peripheral vessels, Lithoplasty™ could enable more effective angioplasty, less frequent bailout stent usage and enhanced lesion preparation prior to the use of drug eluting balloons (DEB) or bio-absorbable vascular scaffolds (BVS). In coronary vessels it could facilitate stent delivery and enhance vessel preparation prior to stent or BVS placement. Finally, in aortic valves the technology could vastly improve native tissue preparation prior to trans-catheter aortic valve replacement (TAVR) and valvuloplasty for those patients not suitable for TAVR.

Nihon Kohden Corp. engages in the medical electronic equipment business. Its products include electrocardiograph, electroencephalograph, evoked potential/EMG, sleep diagnostic, patient monitoring, hematology, hemostasis, ventilation products, and others. The company was founded by Yoshio Ogino on August 7, 1951 and is headquartered in Tokyo, Japan.

Gu'an Bojian Biotechnology Co., Ltd., established on 2014-04-23, Business scope includes general items:Biological product,genetically engineered product,Chinese and western medicine,medical instruments,biological reagent,cosmetic research,to develop;Medical device production;Technology transfer of research and development results of related projects,Technical service and technical consultation;cosmetic,medical instruments,laboratory equipment,Computer hardware and software and peripheral equipment,Machinery and electrical equipment,Labor protection supplies,daily necessities,stationery,Sales of biological reagents;Advertising design and production.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Volcano Co., Ltd. manufactures marine and industrial boiler burners. It offers marine boiler burners and incinerators, which include main boiler burners for LNG carriers, marine pollution preventing equipment, and oil treatment systems and industrial boiler burners, such as co-generation, environmental standards compliance, general purpose, energy saving type, and industrial boiler burners. The firm also provides burner for incinerator disposing of urban wastes, sludge, and industrial wastes, organic, alkaline, and waste liquid incineration facilities and direct combustion deodorization. The company was founded by Benji Okihara on September 3, 1928 and is headquartered in Osaka, Japan.

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.